Your browser doesn't support javascript.
loading
Edoxaban prevented adverse effects including pyrexia and elevation of D-dimer caused by the combination of BRAF and MEK inhibitors in a patient with BRAF-mutant melanoma.
Mukai, Kei; Kamata, Masahiro; Miyazaki, Mirei; Nagata, Mayumi; Fukaya, Saki; Hayashi, Kotaro; Fukuyasu, Atsuko; Ishikawa, Takeko; Ohnishi, Takamitsu; Tada, Yayoi; Tanaka, Takamitsu.
Affiliation
  • Mukai K; Department of Dermatology, Teikyo University School of Medicine, Tokyo, Japan.
  • Kamata M; Department of Dermatology, Teikyo University School of Medicine, Tokyo, Japan.
  • Miyazaki M; Department of Dermatology, Teikyo University School of Medicine, Tokyo, Japan.
  • Nagata M; Department of Dermatology, Teikyo University School of Medicine, Tokyo, Japan.
  • Fukaya S; Department of Dermatology, Teikyo University School of Medicine, Tokyo, Japan.
  • Hayashi K; Department of Dermatology, Teikyo University School of Medicine, Tokyo, Japan.
  • Fukuyasu A; Department of Dermatology, Teikyo University School of Medicine, Tokyo, Japan.
  • Ishikawa T; Department of Dermatology, Teikyo University School of Medicine, Tokyo, Japan.
  • Ohnishi T; Department of Dermatology, Teikyo University School of Medicine, Tokyo, Japan.
  • Tada Y; Department of Dermatology, Teikyo University School of Medicine, Tokyo, Japan.
  • Tanaka T; Department of Dermatology, Teikyo University School of Medicine, Tokyo, Japan.
J Dermatol ; 48(5): 707-709, 2021 May.
Article in En | MEDLINE | ID: mdl-33600004

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Skin Neoplasms / Melanoma Limits: Humans Language: En Journal: J Dermatol Year: 2021 Document type: Article Affiliation country: Japan Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Skin Neoplasms / Melanoma Limits: Humans Language: En Journal: J Dermatol Year: 2021 Document type: Article Affiliation country: Japan Country of publication: United kingdom